Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0001789970-26-000010

General Counsel sold 13,917 shares at an average $30.13 ($419,263)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hanson Kristopher · General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-11 Sale : show line 1 in the form 10b5-1 −284 $27.61 $7,841 175,964 D
2026-05-11 Sale : show line 2 in the form 10b5-1 −846 $28.70 $24,280 175,118 D
2026-05-11 Sale : show line 3 in the form 10b5-1 −6,979 $30.04 $209,649 168,139 D
2026-05-11 Sale : show line 4 in the form 10b5-1 −5,808 $30.56 $177,492 162,331 D
Open-market sales · 13,917 sh · avg $30.13 · $419,263
Loading xslF345X06/form4-05112026_090506.xml…